Serum levels of vascular endothelial growth factor-A and -B in patients with advanced non-small cell lung cancer treated with pembrolizumab: prognostic and predictive value - Vienna 2024

Molecular pathways in lung cancer

Chair(s): Daniela Xhemalaj, Veronica Manolache

Session type: Poster session

Serum levels of vascular endothelial growth factor-A and -B in patients with advanced non-small cell lung cancer treated with pembrolizumab: prognostic and predictive value

Eleni Kokkotou

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Serum levels of vascular endothelial growth factor-A and -B in patients with advanced non-small cell lung cancer treated with pembrolizumab: prognostic and predictive value

Eleni Kokkotou

Poster

Abstract

TMB, genetic alterations and PD-L1 expression in non-small cell lung cancer

Giedr? Gurevi?ien?

Poster

Abstract

Distribution characteristics of infiltrating PD-L1+ lymphocytes in the tumor microenvironment of early-stage NSCLC

Giedr? Gurevi?ien?

Poster

Abstract

The interplay between a fibrotic ECM and lung cancer cell behavior

Samaneh Toukhanbeigli

Abstract

Real-world NGS testing results and treatment modalities in lung cancer: Data update from LALUCA - Landsteiner Lung Cancer Research Platform

Anna Lang-st?berl

Poster

Abstract

Comparison of PD-L1 immunohistochemistry assays for non-small-cell lung cancer

Goohyeon Hong

Abstract

A potential anticancer effect of a new molecule named 4g on lung cancer cell line H292

Elisabetta Pace

Claudia D Anna

Poster

Abstract

Desmethylclomipramine triggers mitochondrial damage and death in TGF-?-induced mesenchymal type of A549 cells

Chia-ling Chen

Poster

Abstract

Patterns of PD-L1 expression and tumor infiltrating immune cells in resected NSCLC

Giedr? Gurevi?ien?

Poster

Abstract

Helper T cell changes in peripheral blood of metastatic non-small cell lung cancer patients receiving cryotherapy and immunotherapy

Gediminas Vasiliauskas

Poster

Abstract

CELLS CYCLE GENES IN CANCER STEM CELLS MOSTLY ASSOCIATED TO RECURRENCE IN NON-SMALL CELL LUNG CANCER (NSCLC).

Beatrice Aramini

Poster

Abstract

Metastasis-on-chip: Exploring the effect of vascular endothelial growth factor (VEGF) on cancer cell extravasation in vitro

Karin Farah Schmid (- Rechberger)

Poster

Abstract

HDAC Inhibitor, CG-745 Inhibit EMT and Induce Apoptosis in Non-small Cell Lung Cancer

Hak-ryul Kim

Poster

Abstract

PIM2 Kinase Inhibitors Affect Lung Cancer through Endoplasmic Reticulum Stress

Zhijing Shi

Poster

Abstract

Multigene Testing Satus in 257 Lung Squamous Cell Carcinoma Cases: Clinical Profiling of BRAF V600E Mutation in Three Cases

Naozumi Hashimoto

Abstract

Sensitising mutations in lung adenocarcinomas causing malignant pleural effusion: impact on survival

Craig Mounsey

Poster

Abstract

The expressional patterns and molecular mechanisms of LGI3(Leucine-rich-repeat LGI family member-3) were heterogenous in different non-small cell lung cancer cell lines.

Jong Wook Shin

Poster

Abstract

The impact of mutation analysis on prognosis in advanced-stage lung adenocarcinoma

Elif ?en

Ahmet Melih Sahin

Poster

Abstract

The current status of lung cancer multi-gene testing for non-small cell lung cancer diagnosed by EBUS-TBNA

Hideki Makino

Abstract

Deciphering Landscape of Driver Transcription Factors in Large Cell Neuroendocrine Carcinoma (LCNEC) of the Lungs Through a Novel Bioinformatics Approach

Ilona Tietzova

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}